Septerna (SEPN) EPS (Weighted Average and Diluted) (2023 - 2026)
Septerna (SEPN) recorded quarterly EPS (Weighted Average and Diluted) of -$0.19 in Q1 2026, up 20.83% quarter-over-quarter from -$0.24 in Q4 2025, and up 61.22% on a YoY basis from -$0.12 in Q1 2025.
Septerna (SEPN) EPS (Weighted Average and Diluted) (2023 - 2026) Analysis & Trends
Septerna's EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$0.19 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 61.22% year-over-year to -$0.19; the TTM figure through Mar 2026 stood at -$0.81 (up 38.17% YoY), while the FY2025 annual figure was -$1.1, up 84.85% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.19 for Q1 2026 at Septerna, up from -$0.24 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $16.78 in Q4 2023 to a low of -$8.4 in Q3 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.26 across 4 years, with a median of -$0.49 in 2025.
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 102.14% in 2025; the steepest drop was 101.64% in 2025.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at $16.78 in 2023, then retreated by 12.93% to $14.61 in 2024, then plunged by 101.64% to -$0.24 in 2025, then rose by 20.83% to -$0.19 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.19 (Q1 2026), -$0.24 (Q4 2025), and $0.18 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.19 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | -0.56 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | 14.61 |
| Sep 30, 2024 | -8.40 |
| Jun 30, 2024 | -7.03 |
| Mar 31, 2024 | -6.35 |
| Dec 31, 2023 | 16.78 |
| Sep 30, 2023 | -5.45 |